The Carlo Oncology Suite V3 is a fully integrated deterministic modelling engine for malignant behaviour. It unifies structural rules, pressure dynamics, operator interactions, ecosystem behaviour, intervention physics, and forward‑trajectory prediction into a single conceptual framework capable of describing tumour behaviour at every structural scale. The suite consists of eight interconnected documents: a behavioural substrate defining foundational fields; an operator engine governing malignant forces; a behavioural dynamics framework describing transitions and modes; a multi‑agent ecosystem model capturing node‑to‑node interaction; a kill‑term intervention engine formalising external pressure; a prediction layer mapping future trajectories; an expanded ethical containment document; and a reader’s guide supporting accessibility and responsible use. With the V3.1 Addendum, the suite incorporates the deterministic pressure→behaviour transfer function, completing the mathematical bridge between pressure, operators, ecosystem state, and behavioural change. This addition finalises the deterministic structure of V3, ensuring pressure is treated as an internal driver rather than an external influence. V3 advances the Carlo framework into a broader conceptual domain, introducing ecosystem‑scale interaction calculus, collapse‑cascade and resistance‑wave propagation, kill‑term timing and failure‑mode physics, rare‑mode behaviour mapping, trajectory‑based prediction fields, and a unified ethical boundary system. Every component is transparent, reproducible, browser‑native, and free of external dependencies. The Carlo Oncology Suite V3 provides researchers, students, and developers with a deterministic environment for understanding how malignant systems evolve under pressure, how multi‑agent interactions shape behaviour, how intervention forces propagate through ecosystems, and how trajectories can be reasoned through explicit rules. It is a conceptual engine — not a clinical tool — and must not be used for diagnosis, treatment guidance, or medical decision‑making. This release includes two supplementary documents: the Full Diagram Compendium (V3.1 Ultra) and the Kill‑Term Flagship Diagram Pack, providing enhanced ASCII‑based visualisations of the suite’s deterministic architecture. This release of Oncology V3 is now also accompanied by the Behavioural Oncology Compendium, a consolidated operator-level reference containing all extended behavioural mechanisms, gradients, transitions, and microenvironmental drivers documented to date. The compendium is included in full as part of this package and serves as the supplementary behavioural atlas for V3. Author’s Intent: I built this engine because I wanted to stand against cancer in the only way I knew how — by making its behaviour readable, structured, and impossible to ignore. I cannot change biology, but I can challenge the confusion that surrounds it. If this work helps someone understand malignant systems with more clarity, more confidence, or more courage than before, then it has already done its job. — Matt keywords: mathematical oncology deterministic modelling tumour dynamics tumour growth models logistic growth gompertz model von bertalanffy model exponential growth pharmacokinetics drug concentration modelling treatment response chemotherapy radiotherapy targeted therapy immunotherapy resistance modelling sensitive and resistant populations mutation flow models optimisation control theory dose scheduling deterministic engines browser-native modelling single-file engines reproducible simulations clarity-focused modelling educational modelling conceptual modelling tumour microenvironment modelling phase portraits dynamical systems stability analysis carrying capacity modelling tumour heterogeneity modelling deterministic seedspace modelling model library mathematical appendix oncology primer deterministic simulation loops pure functions no dependencies tumour treatment trade-offs toxicity modelling parameter uncertainty sensitivity analysis deterministic visualisation canvas-based modelling svg-based modelling tumour trajectory analysis resistance takeover modelling bolus dosing periodic dosing pulsed dosing ramp dosing deterministic pharmacokinetics tumour-drug interaction modelling immune interaction sketch spatial diffusion sketch deterministic modelling philosophy clarity minimalism transparency reproducibility ethical modelling responsible modelling non-clinical modelling educational oncology tools deterministic engine specification developer handbook conceptual companion notes modelling reflections modelling context deterministic research artefacts carlo ecosystem carlo oncology suite tumour modelling frameworks deterministic computational oncology deterministic browser engines tumour modelling education tumour modelling research tumour modelling tools tumour modelling clarity tumour modelling transparency tumour modelling reproducibility tumour modelling ethics tumour modelling philosophy deterministic cancer modelling deterministic tumour simulation deterministic treatment simulation deterministic resistance simulation deterministic drug simulation deterministic optimisation deterministic dose scheduling deterministic tumour dynamics deterministic modelling suite deterministic oncology suite deterministic modelling notes deterministic modelling companion deterministic modelling appendix deterministic modelling primer deterministic modelling specification deterministic modelling handbook Contact: For enquiries or research questions related to this work, email matthewcarlo.research@gmail.com
Matthew Arthur Carlo (Mon,) studied this question.